$BKLLF / $CODE This transformative delivery system will initially seek approval through the FDA 505(b)(2) accelerated pathway provisions.
https://stockhouse.com/news/press-releases/20...ransdermal
https://stockhouse.com/news/press-releases/20...ransdermal